-
Functional Areas
- Principal Recipient Start-Up
-
Legal Framework
- Overview
- Project Document
-
The Grant Agreement
- UNDP-Global Fund Grant Regulations
- Grant Confirmation
- Grant Confirmation: Face Sheet
- Grant Confirmation: Conditions
- Grant Confirmation: Conditions Precedent (CP)
- Grant Confirmation: Special Conditions (SCs)
- Grant Confirmation: Schedule 1, Integrated Grant Description
- Grant Confirmation: Schedule 1, Performance Framework
- Grant Confirmation: Schedule 1, Summary Budget
- Implementation Letters and Performance Letters
- Agreements with Sub-recipients
- Agreements with Sub-sub-recipients
- Signing Legal Agreements and Requests for Disbursement
- Language of the Grant Agreement and other Legal Instruments
- Amending Legal Agreements
- Other Legal and Implementation Considerations
- Legal Framework for Other UNDP Support Roles
-
Health Product Management
- Overview - Health Product Management
- UNDP Quality Assurance Policy
- Product Selection
- Quantification and Forecasting
- Supply Planning of Health Products
-
Sourcing and regulatory aspects
- Global Health Procurement Center (GHPC)
- Development of List of Health Products
- Development of the Health Procurement Action Plan (HPAP)
- Health Procurement Architecture
- Local Procurement of health products
- Procurement of Pharmaceutical Products
- Procurement of non-pharmaceutical Health Products
- Other Elements of the UNDP Procurement Architecture
- Submission of GHPC CO Procurement Request Form
- Guidance on donations of health products
- International freight, transit requirements and use of INCOTERMS
- Inspection and Receipt
- Storage
- Inventory Management
- Distribution
- Quality monitoring of health products
- Waste management
- Rational use
- Pharmacovigilance
- Risk Management for PSM of health products
- Compliance with the Global Fund requirements
- UNDP Health PSM Roster
-
Financial Management
- Overview
- Grant-Making and Signing
- Grant Implementation
- Sub-recipient Management
- Grant Reporting
- Grant Closure
- CCM Funding
- Import duties and VAT / sales tax
-
Monitoring and Evaluation
- Overview
- Differentiation Approach
- Monitoring and Evaluation Components of Funding Request
- Monitoring and Evaluation Components of Grant Making
- M&E Components of Grant Implementation
- Sub-Recipient Management
- Grant Reporting
-
Capacity development and transition, strengthening systems for health
- Overview
- Interim Principal Recipient of Global Fund Grants
- A Strategic Approach to Capacity Development
- Resilience and Sustainability
- Legal and Policy Enabling Environment
- Functional Capacities
- Capacity Development and Transition
- Transition
- Capacity Development Objectives and Transition Milestones
- Capacity Development Results - Evidence From Country Experiences
- Capacity development and Transition Planning Process
- Capacity Development and Transition - Lessons Learned
-
Risk Management
- Overview
- Introduction to Risk Management
-
Risk Management in the Global Fund
- Global Fund Risk Management Framework
- Local Fund Agent
- Challenging Operating Environment (COE) Policy
- Additional Safeguard Policy
- Global Fund Risk Management Requirements for PRs
- Global Fund Risk Management Requirements During Funding Request
- Global Fund Review of Risk Management During Grant Implementation
- Risk management in UNDP
- Risk Management in UNDP-managed Global Fund projects
- UNDP Risk Management Process
- Risk management in crisis settings
- Audit and Investigations
- Human rights, key populations and gender
- Human resources
-
Grant closure
- Overview
- Terminology and Scenarios for Grant Closure Process
-
Steps of Grant Closure Process
- 1. Global Fund Notification Letter 'Guidance on Grant Closure'
- 2. Preparation and Submission of Grant Close-Out Plan and Budget
- 3. Global Fund Approval of Grant Close-Out Plan
- 4. Implementation of Close-Out Plan and Completion of Final Global Fund Requirements (Grant Closure Period)
- 5. Operational Closure of Project
- 6. Financial Closure of Project
- 7. Documentation of Grant Closure with Global Fund Grant Closure Letter
Programmatic Revision / Changes to Performance Framework
During implementation, revisions allow the PR to adjust investments according to the changing context and other needs. This ensures continued effective and efficient use of Global Fund resources to achieve maximum impact in line with National Strategic Plans and the Global Fund’s Strategy. As part of revisions, changes can be made to the implementation period end date, to the Performance Framework, to adjust or reallocate the approved Grant Funds.
A Programmatic Revision (formerly referred to as a “Reprogramming” or “Program Revision”) refers to changes in the scope and/or scale of a Global Fund grant within already approved funding ceiling and current implementation period resulting in changes to the modules, interventions and/or targets in the Performance Framework:
a. Changing the scope is the process of (i) adding or deleting goals and/or objectives, or (ii) changing key interventions (including those related to RSSH, Human Rights, and Gender Equality) either at the level of a grant, or at the level of the Global Fund supported disease or RSSH program. Changes in the scope may result in the addition or removal of indicators in the Performance Framework. b. Changing the scale is the process of increasing or decreasing targets for one or more indicators.
Triggers of Programmatic Revisions
There are a number of potential scenarios which might trigger a Programmatic Revision, such as:
- Changes in the epidemiological pattern of the disease or the trajectory of the disease in the country, resulting in changes to relevant national strategies and key interventions
- Release of new scientific evidence and/or changes to the normative guidance for disease control in the country;
- Changes in implementation arrangements
- The scale-up of effective interventions and innovative approaches, introduction of new health products and removal of health products
- Implementation of interventions to reflect identified capacity gaps and risks;
- Allocation of additional funding to the program;
- Changes in the funding landscape, and/or legal, political and socio-economic environment;
- The need to accelerate the adoption of revised partner technical guidance to ensure patient safety and program efficacy.
- Changes in unit costs, and/or cost of activities;
These scenarios may result in changes to the Performance Framework (adding or deleting goals and objectives, and/or changing key interventions, and/or increasing or decreasing targets).
A Programmatic Revision may be either initiated by the Country Coordinating Mechanism (CCM) and/or Principal Recipient (PR) or the Global Fund Country Team. It can be proposed anytime during grant implementation if warranted by the programmatic context and needs to be completed maximum three calendar months after initiation. All revisions have to be endorsed by the CCM. The Global Fund Country Team may require Local Fund Agent (LFA) review of the request. The scope of the LFA review is to be agreed between the Global Fund and the LFA.
The approval process of the Programmatic Revisions is differentiated based on whether the revision requires the TRP review or not.
Once approved, a Programmatic Revision is reflected in the Grant Agreement through an Implementation Letter. The Implementation Letter is signed by the PR and the Global Fund. For Programmatic Revisions that involve time sensitive changes to the Performance Framework with implications to the performance rating and results rating (such as increasing or decreasing targets or adding missing targets), a Notification Email can be issued to capture PR and Global Fund agreement on the Performance Framework changes and enable Performance Framework updates in the Global Fund system. The Performance Framework changes are formalized with an Implementation Letter at a later stage.